Monounsaturated Fatty Acid-Enriched Diet Decreases Plasma Plasminogen Activator Inhibitor Type 1

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 16; no. 1; pp. 82 - 88
• Main Authors: Lopez-Segura, F, Velasco, F, Lopez-Miranda, J, Castro, P, Lopez-Pedrera, R, Blanco, A, Torres, A, Trujillo, J, Ordovas, J.M, Perez-Jiminez, F
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01.01.1996; Hagerstown, MD Lippincott
• Subjects: Adult; Biological and medical sciences; Cholesterol - blood; Cholesterol, HDL - blood; Dietary Carbohydrates - administration & dosage; Dietary Fats - administration & dosage; Diseases of the cardiovascular system; Fatty Acids, Monounsaturated - administration & dosage; Humans; Insulin - blood; Lipoproteins, VLDL - blood; Male; Medical sciences; Plasminogen Activator Inhibitor 1 - blood; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Triglycerides - blood; Vascular disease; Human; u-Plasminogen activator; Serine endopeptidases; Enzyme; Atherosclerosis; Cardiovascular disease; Hydrolases; Unsaturated fatty acid; Supplemented diet; Proteinases; Blood plasma
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/01.ATV.16.1.82

An increase in levels of plasma plasminogen activator inhibitor type 1 (PAI-1) is one of the main hemostatic alterations in patients with coronary heart disease. Despite growing interest in the fibrinolytic system, few studies have been undertaken to determine the effect exerted on it by the different dietary fatty acids. We investigated the effect of a monounsaturated fat (MUFA)-rich diet in comparison with a low-fat diet (National Cholesterol Education Program step 1 diet) (NCEP-1) on factors involved in blood coagulation and fibrinolysis. We also determined the effect of dietary cholesterol on these blood parameters. Twenty-one young, male, healthy volunteers followed two low-fat/high-carbohydrate diets (< 30% fat, < 10% saturated fat, 14% MUFA) for 24 days each, with 115 or 280 mg of cholesterol per 1000 kcal per day, and two oleic acid-enriched diets (38% fat, 24% MUFA) with the same dietary cholesterol as the low-fat/high-carbohydrate diets. Plasma levels of fibrinogen, thrombin-antithrombin complexes, prothrombin fragments 1 + 2, plasminogen, alpha2 antiplasmin, and tissue plasminogen activator were not significantly different among the experimental diets used in this study. Consumption of the diet rich in MUFA resulted in a significant decrease in both PAI-I plasma activity (P < .005) and antigenic PAI-1 (P < .04) compared with the carbohydrate-rich diet (NCEP-1). The addition of dietary cholesterol to each of these diets did not result in any significant additional effect. Changes in insulin levels and PAI-1 activity were positively correlated (r = .425; P < .02). In conclusion, consumption of diets rich in MUFAs decreases PAI-1 plasma activity, which is accompanied by a parallel decrease in plasma insulin levels. (Arterioscler Thromb Vasc Biol. 1996;16:82-88.)